Other

Pfizer in talks on $5 billion acquisition: media

American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.

Diseases, Conditions, Syndromes

World at war on virus as China offers ray of hope

The world stepped up its war on coronavirus as deaths soared again in Europe on Thursday, despite a sign of hope from China where zero new domestic cases were reported for the first time.

Other

Philips faces fresh hit from toxic foam recall

Dutch electronics giant Philips said Wednesday it has set aside a further 225 million euros for a recall of faulty respiratory equipment that puts users at risk of inhaling toxic foam.

Diseases, Conditions, Syndromes

Shanghai starts China's biggest COVID-19 lockdown in 2 years

China began its most extensive coronavirus lockdown in two years Monday to conduct mass testing and control a growing outbreak in Shanghai as questions are raised about the economic toll of the nation's "zero-COVID" strategy.

Medications

Novartis generics unit Sandoz makes stock market debut

Swiss generic drugs group Sandoz began trading as an independent company in Zurich on Wednesday, in a stock market debut following a spin-off by parent company Novartis as it pivots toward new drug development.

page 2 from 14